Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease. | Eur J Pediatr | 2023 | 36997768 | PubTator, text mining | PubMed |
| Unraveling the genetics of transformed splenic marginal zone lymphoma. | Blood Adv | 2023 | 36995085 | PubTator, text mining | PubMed |
| Genetic regulation of fetal hemoglobin across global populations. | medRxiv | 2023 | 36993312 | PubTator, text mining | PubMed |
| Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials. | Viruses | 2023 | 36992422 | PubTator, text mining | PubMed |
| Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing. | Drug Deliv Transl Res | 2023 | 36988873 | PubTator, text mining | PubMed |
| Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022. | Int J Mol Sci | 2023 | 36982263 | PubTator, text mining | PubMed |
| Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing. | Genes (Basel) | 2023 | 36980849 | PubTator, text mining | PubMed |
| The Potential Revolution of Cancer Treatment with CRISPR Technology. | Cancers (Basel) | 2023 | 36980699 | PubTator, text mining | PubMed |
| Retinoic Acid and Retinoid X Receptors. | Cells | 2023 | 36980205 | PubTator, text mining | PubMed |
| Genetic variation in cis-regulatory domains suggests cell type-specific regulatory mechanisms in immunity. | Commun Biol | 2023 | 36977773 | PubTator, text mining | PubMed |
| Network-Based Method to Investigate the Promoted Cell Apoptosis Mechanisms of Oridonin in OSCC through the RNA-Transcriptome. | J Immunol Res | 2023 | 36969496 | PubTator, text mining | PubMed |
| High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis. | Front Genome Ed | 2023 | 36969374 | PubTator, text mining | PubMed |
| Immunomodulation-a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system. | Front Immunol | 2023 | 36969193 | PubTator, text mining | PubMed |
| The Type 2 Diabetes Knowledge Portal: An open access genetic resource dedicated to type 2 diabetes and related traits. | Cell Metab | 2023 | 36963395 | PubTator, text mining | PubMed |
| Efficient non-viral delivery of macromolecules in human primary hematopoietic stem cells and lymphocytes. | J Mol Cell Biol | 2023 | 36945107 | PubTator, text mining | PubMed |
| Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire. | Cancer Immunol Immunother | 2023 | 36943460 | PubTator, text mining | PubMed |
| Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. | Nat Genet | 2023 | 36928603 | PubTator, text mining | PubMed |
| Exosomal circular RNAs: New player in breast cancer progression and therapeutic targets. | Front Genet | 2023 | 36926585 | PubTator, text mining | PubMed |
| In search of an ideal template for therapeutic genome editing: A review of current developments for structure optimization. | Front Genome Ed | 2023 | 36911237 | PubTator, text mining | PubMed |
| Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: A review. | Front Med (Lausanne) | 2023 | 36910492 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=24